HIV risk reduction strategies are evolving with important implications for HIV research to be further investigated.
Scroll to Top
CLICK FOR GP-41 DISCONTINUATION NOTICE
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025
